Trial intelligence / Profile preview

UPGRADE: Cholecalciferol vs Ergocalciferol in CKD

NCT01173848Phase 3Terminated

Sponsor
Cleveland Clinic
Start
Jul 2010
Primary completion
Sep 2011
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of vitamin d in vitamin D deficiency and secondary hyperparathyroidism (SHPT), sponsored by Cleveland Clinic. Started Jul 2010; status: terminated.

02

Drugs

vitamin d
03

Conditions

vitamin D deficiencysecondary hyperparathyroidism (SHPT)

Beyond the preview

Go deeper on NCT01173848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01173848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call